Viridian Therapeutics, Inc. VRDN
- Lumvoa — Thyroid Eye Disease Approved
- elegrobart — Thyroid Eye Disease Phase 3
IGF-1R (2 companies · 3 programs)
Companies with an active program directed at IGF-1R.
Zenas BioPharma, Inc. ZBIO
- ZB001 — Thyroid Eye Disease Phase 1